SeqWright, Courting Caution, Says Next-Gen Sequencers Not Quite Ready for Its Shop | GenomeWeb
SeqWright last week said it won a large-scale contract from the US Department of Agriculture to sequence 1,000 influenza virus genomes.
 
But the company, which prides itself as an early adopter of emerging DNA analysis tools, believes the time is not quite right for bringing next-generation sequencing in-house for this or other projects — particularly for producing sequencing data that meet US Food and Drug Administration standards, a special focus of the firm.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.